New insider Mintz Mark claimed ownership of 6,350 shares (SEC Form 3)
$CRL
Biotechnology: Commercial Physical & Biological Resarch
Health Care
| FORM 3 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
|
|||||||||||||||
1. Name and Address of Reporting Person*
(Street)
|
2. Date of Event Requiring Statement
(Month/Day/Year) 06/01/2025 |
3. Issuer Name and Ticker or Trading Symbol
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. [ CRL ] |
|||||||||||||
|
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
|
5. If Amendment, Date of Original Filed
(Month/Day/Year) |
||||||||||||||
6. Individual or Joint/Group Filing (Check Applicable Line)
| |||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Common Stock | 6,350(1) | D | |
|
Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Stock Options (Right to Buy) | 03/01/2022(2) | 03/01/2031 | Common Stock | 3,219 | $289.61 | D | |
| Stock Options (Right to Buy) | 05/28/2022(2) | 05/28/2031 | Common Stock | 1,098 | $337.99 | D | |
| Stock Options (Right to Buy) | 05/27/2023(3) | 05/27/2032 | Common Stock | 1,437 | $244.41 | D | |
| Stock Options (Right to Buy) | 05/26/2024(4) | 05/26/2033 | Common Stock | 1,730 | $194.12 | D | |
| Stock Options (Right to Buy) | 05/31/2025(5) | 05/31/2034 | Common Stock | 1,635 | $208.44 | D | |
| Explanation of Responses: |
| 1. Includes (a) 133 restricted stock units (RSUs) which vest on 5/27/2026, (b) 361 restricted stock units (RSUs) which vest as follows: 180 on 5/26/2026 and 181 on 5/26/2027, (c) 540 restricted stock units (RSUs) which vest as follows: 180 on 5/31/2026, 180 on 5/31/2027 and 180 on 5/31/2028 and (d) 3,244 restricted stock units (RSUs) which vest as follows: 811 on 5/30/2026, 811 on 5/30/2027, 811 on 5/30/2028 and 811 on 5/30/2029. |
| 2. Stock Options fully vested. |
| 3. 1,077 Stock Options are vested, and the remaining Stock Options will vest on 5/27/2026. |
| 4. 865 Stock Options are vested, and the remaining Stock Options will vest as follows: 432 on 5/26/2026 and 433 on 5/26/2027. |
| 5. 408 Stock Options are vested, and the remaining Stock Options will vest as follows: 409 on 5/31/2026, 409 on 5/31/2027 and 409 on 5/31/2028. |
| /s/ Mark Mintz | 06/10/2025 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||